Dr. Quesada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-500-0712
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2015 - 2017
University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 2011 - 2015
McGovern Medical School at UTHealthClass of 2011
Certifications & Licensure
NY State Medical License 2018 - 2025
TX State Medical License 2015 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage.Georgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, Kelly S Chien, Andres E Quesada
Cancer. 2024-10-15 - 1 citationsOptical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia.Sanam Loghavi, Qing Wei, Farhad Ravandi, Andres E Quesada, Mark J Routbort
American Journal of Hematology. 2024-10-01 - Low-dose cytarabine and hypomethylating agents for Down syndrome with acute myeloid leukemia.Ramya Ramakrishnan, Faryal Munir, Andres Ernesto Quesada, Johann Hitzler, Branko Cuglievan
Pediatric Blood & Cancer. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
